Preview

Fine Chemical Technologies

Advanced search

Implementation of pharmaceutical development using multivariate analysis of multi-criteria optimization on the example of the stage of purification of oligohexamethyleneguanidine hydrosuccinate

https://doi.org/10.32362/2410-6593-2023-18-3-265-279

Full Text:

Abstract

Objectives. The study set out to use mathematical modeling, in particular the method of multifactorial analysis of multicriteria optimization (MAMO), in the development of a pharmaceutical product.

Methods. After carrying out experimental tests based on the proposed algorithmic sequence, the obtained data were interpreted using MAMO.

Results. The possibility of using MAMO to solve the applied problem of purifying oligohexamethyleneguanidine hydrosuccinate (OHMG-HS), considered as a pharmaceutical precursor for the creation of medicines, was demonstrated.

Conclusions. The expediency of using the proposed algorithm as a tool for pharmaceutical development is substantiated by identifying dependencies of the influence of purification conditions on the final content of admixtures in the target product.

About the Authors

D. O. Shatalov
MIREA – Russian Technological University (M.V. Lomonosov Institute of Fine Chemical Technologies)
Russian Federation

Denis O. Shatalov, Can. Sci. (Pharm.), Associate Professor, Department of Biotechnology and Industrial Pharmacy

86, Vernadskogo pr., Moscow, 119571

ResearсherID H-9408-2013

Scopus Author ID 57060435900 



K. N. Trachuk
MIREA – Russian Technological University (M.V. Lomonosov Institute of Fine Chemical Technologies)
Russian Federation

Kirill N. Trachuk, Student, Department of Biotechnology and Industrial Pharmacy

86, Vernadskogo pr., Moscow, 119571 



A. V. Aydakova
Institute of Pharmaceutical Technologies
Russian Federation

Anna V. Aydakova, Technologist

86, Vernadskogo pr., Moscow, 119571 



D. A. Akhmedova
MIREA – Russian Technological University (M.V. Lomonosov Institute of Fine Chemical Technologies)
Russian Federation

Diana A. Akhmedova, Postgraduate Student, Department of Biotechnology and Industrial Pharmacy

86, Vernadskogo pr., Moscow, 119571

Scopus Author ID 57218775331 



I. S. Ivanov
Institute of Pharmaceutical Technologies
Russian Federation

Ivan S. Ivanov, Technologist

86, Vernadskogo pr., Moscow, 119571

Scopus Author ID 57372716000 



D. S. Minenkov
Ishlinsky Institute for Problems of Mechanics, Russian Academy of Sciences
Russian Federation

Dmitry S. Minenkov, Cand. Sci. (Phys.-Math.)

101, Vernadskogo pr., Moscow, 119526

ResearсherID M-8037-2015

Scopus Author ID 36010696700 



I. Yu. Blazhevich
M.V. Lomonosov Moscow State University
Russian Federation

Igor Yu. Blazhevich, Student, Faculty of Mechanics and Mathematics

1, Kolmogorova ul., Moscow, 119234 



S. A. Kedik
MIREA – Russian Technological University (M.V. Lomonosov Institute of Fine Chemical Technologies); Institute of Pharmaceutical Technologies
Russian Federation

Stanislav A. Kedik, Dr. Sci. (Eng.), Professor, Head of the Department of Biotechnology and Industrial Pharmacy; General Director

86, Vernadskogo pr., Moscow, 119571

Scopus Author ID 7801632547 



References

1. Singh K.S., Anand S., Dholpuria S., Sharma J.K., Shouche Y. Antimicrobial Resistance Paradigm and OneHealth Approach. In: Panwar H., Sharma C., Lichtfouse E. (Eds.). Sustainable Agriculture Reviews 46. Mitigation of Antimicrobial Resistance. 2020. V. 46. P. 1–32. https://doi.org/10.1007/978-3-030-53024-2_1

2. La-Rosa R., Johansen H.K., Molin S. Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution. Antibiotics. 2022;11(3):419. https://doi.org/10.3390/antibiotics11030419

3. Davydov D.S. The National Strategy of the Russian Federation for Preventing the Spread of Antimicrobial Resistance: Challenges and Prospects of Controlling One of the Global Biological Threats of the 21st Century. BIOpreparaty. Profilaktika, diagnostika, lechenie = BIOpreparations. Prevention, Diagnostics, Treatment. 2018;18(1):50–56 (in Russ.). https://doi.org/10.30895/2221-996X-2018-18-1-50-56

4. Kedik S.A., Shatalov D.O., Norin A.M., Belyakov S.V., Ivanov I.S., Aidakova A.V. Method for the separation of branched oligohexamethylenguanidine salts for their use as pharmaceutical substances (variants): RF Pat. RU2750869. Publ. 07.05.2021 (in Russ.).

5. Shatalov D.O., Kedik S.A., Belyakov S.V., Ivanov I.S., Aidakova A.V., Sedishev I.P. Method of producing branched oligohexamethylene guanidine salts having degree of purity sufficient for use thereof as pharmaceutical substance: RF Pat. RU2729421. Publ. 06.08.2020 (in Russ.).

6. Shatalov D.O., Kedik S.A., Ivanov I.S., et al. Development of a Promising Method for Producing Oligomeric Mixture of Branched Alkylene Guanidines to Improve Substance Quality and Evaluate their Antiviral Activity Against SARS-CoV-2. Molecules. 2021;26(11):3472. https://doi.org/10.3390/molecules26113472

7. Belyakov S.V., Kedik S.A., Krupenchenkova N.V., Demenyuk P.Yu., Shatalov D.O. The effect of branched oligo(hexamethylene)guanidine hydrochloride against clinically significant pathogens. Biofarmatsevticheskii zhurnal = Russ. J. Biopharml. 2019;11(6):28–37 (in Russ.).

8. Kedik S.A., Shatalov D.O., Panov A.V., Aidakova A.V., Ivanov I.S., Belyakov S.V. Combined drug preparation in form of solution for preparing spray for treating diseases of oral cavity: RF Pat. RU2687745. Publ. 16.05.2019 (in Russ.).

9. Kedik S.A., Shatalov D.O., Kovalenko A.V., Aidakova A.V. Ophthalmic preparation in the form of eye drops for preventing and treating infectious conjunctivitis caused by bacteria and viruses: RF Pat. RU2699377. Publ. 09.05.2019 (in Russ.).

10. Akhmedova D.A., Shatalov D.O., Ivanov I.S., Aydakova A.V., Herbst A., Greiner L., Kaplun A.P., Zhurbenko A.S., Kedik S.A. The use of microfluidic hardware in the synthesis of oligohexamethylene guanidine derivatives. Tonk. Khim. Tekhnol. = Fine Chem. Technol. 2021;16(4):307–317 (Russ., Eng.). https://doi.org/10.32362/2410-6593-2021-16-4-307-317

11. Braun D., Sherdron G., Kern V. Prakticheskoe rukovodstvo po sintezu i issledovaniyu svoistv polimerov (A Practical Guide to the Synthesis and Study of the Properties of Polymers): transl. from German. Moscow: Khimiya; 1976. 256 p. (in Russ.). [Brown D., Sherdron G., Kern V. Praktikum der Makromolekularen Organischen Chemie. Heidelberg: Alfred Huthig, 1971.]

12. Efimov K.M., Gembitskii P.A., Martynenko S.V. Method for purification polyguanidine disinfecting agent from parent monomers: RF Pat. RU2237682. Publ. 10.10.2004 (in Russ.).

13. Antony J. Design of Experiments for Engineers and Scientists. First edition. Elsevier Science & Technology Books; 2003. 156 p.

14. Grzhibovsky A.M. The choice of a statistical criterion for testing hypotheses. Ekologiya cheloveka = Human Ecology. 2008;(11):48–57 (in Russ.).


Supplementary files

1. Results of oligohexamethyleneguanidine hydrosuccinate optimization with carbon tetrachloride
Subject
Type Исследовательские инструменты
View (106KB)    
Indexing metadata
  • The possibility of using multifactorial analysis of multicriteria optimization to solve the applied problem of purifying oligohexamethyleneguanidine hydrosuccinate, considered as a pharmaceutical precursor for the creation of medicines, was demonstrated.
  • The expediency of using the proposed algorithm as a tool for pharmaceutical development is substantiated by identifying dependencies of the influence of purification conditions on the final content of admixtures in the target product.

Review

For citations:


Shatalov D.O., Trachuk K.N., Aydakova A.V., Akhmedova D.A., Ivanov I.S., Minenkov D.S., Blazhevich I.Yu., Kedik S.A. Implementation of pharmaceutical development using multivariate analysis of multi-criteria optimization on the example of the stage of purification of oligohexamethyleneguanidine hydrosuccinate. Fine Chemical Technologies. 2023;18(3):265-279. https://doi.org/10.32362/2410-6593-2023-18-3-265-279

Views: 67


ISSN 2410-6593 (Print)
ISSN 2686-7575 (Online)